(XDNY) Xtrackers MSCI Japan ESG - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00BPVLQD13 • Japan Large-Cap Equity

XDNY: Japanese, Stocks, Equities, Shares

The Xtrackers MSCI Japan ESG Screened UCITS ETF 1D (XETRA: XDNY) is designed to track the performance of the JPX-Nikkei Index 400, a benchmark that includes 400 Japanese companies. These companies are selected based on specific criteria: they must have been listed for at least three years, have more assets than liabilities, no operating or overall deficit, and not be marked for delisting. The index is rebalanced annually and includes companies from the Tokyo Stock Exchanges First Section (large caps), Second Section (mid-caps), and Mothers section (high-growth and emerging stocks), as well as the JASDAQ stock exchange.

The ETF is domiciled in Ireland and is part of the Xtrackers suite of products, known for their transparency and cost-efficiency. With an AUM of approximately €18.37 billion, it is one of the larger ETFs tracking Japanese equities. The fund is listed on XETRA, making it accessible to European investors. The Morningstar Japan TME NR JPY index serves as its reference, ensuring that the ETF reflects the total return of the underlying securities in Japanese yen terms.

Investors should note that this ETF provides exposure to a broad range of Japanese companies, from large-cap firms in the First Section to smaller, growth-oriented companies in the Mothers section. The inclusion of JASDAQ-listed companies adds exposure to the Japanese venture and growth sectors. The funds ESG-screened approach ensures that it aligns with sustainability preferences, making it a compelling option for investors seeking both financial return and environmental, social, and governance alignment.

For fund managers and investors, the ETF offers a diversified portfolio of 400 companies, reducing single-stock risk. The annual rebalancing ensures that the index maintains its focus on companies with strong financial health and liquidity. Additionally, the ETFs structure as a UCITS-compliant fund provides regulatory oversight and investor protections under the European Unions Undertakings for Collective Investment in Transferable Securities framework.

Additional Sources for XDNY ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

XDNY ETF Overview

Market Cap in USD 19,292m
Category Japan Large-Cap Equity
TER 0.16%
IPO / Inception 2015-03-31

XDNY ETF Ratings

Growth 5y 49.9%
Fundamental -
Dividend 21.6%
Rel. Strength Industry -14.7
Analysts -
Fair Price Momentum 14.29 EUR
Fair Price DCF -

XDNY Dividends

Dividend Yield 12m 0.87%
Yield on Cost 5y 1.22%
Annual Growth 5y 0.24%
Payout Consistency 88.9%

XDNY Growth Ratios

Growth Correlation 3m 57.9%
Growth Correlation 12m 46.7%
Growth Correlation 5y 73.3%
CAGR 5y 7.56%
CAGR/Max DD 5y 0.34
Sharpe Ratio 12m 0.36
Alpha -8.76
Beta 0.91
Volatility 14.76%
Current Volume 9.2k
Average Volume 20d 33.3k
What is the price of XDNY stocks?
As of February 22, 2025, the stock is trading at EUR 16.17 with a total of 9,220 shares traded.
Over the past week, the price has changed by +0.00%, over one month by +3.51%, over three months by +5.26% and over the past year by +8.74%.
Is Xtrackers MSCI Japan ESG a good stock to buy?
Partly, yes. Based on ValueRay Analyses, Xtrackers MSCI Japan ESG (XETRA:XDNY) is currently (February 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 49.89 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XDNY as of February 2025 is 14.29. This means that XDNY is currently overvalued and has a potential downside of -11.63%.
Is XDNY a buy, sell or hold?
Xtrackers MSCI Japan ESG has no consensus analysts rating.
What are the forecast for XDNY stock price target?
According to ValueRays Forecast Model, XDNY Xtrackers MSCI Japan ESG will be worth about 17.1 in February 2026. The stock is currently trading at 16.17. This means that the stock has a potential upside of +6%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 17.1 6%